United States

Health News


AstraZeneca ups investment in messenger RNA drugs with Ethris deal 6:03am EDT

FRANKFURT AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million euros ($29 million) on a research alliance with German biotech start-up Ethris.

More Headlines


New Novartis drug takes aim at tough-to-treat malaria

LONDON Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.

3:29am EDT

Samsung Bioepis teams up with Takeda to develop original biotech drugs

SEOUL Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.

Japan Aug 20 2017

Bayer, J&J win third U.S. trial over Xarelto bleeding risk

A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding.

Aug 18 2017

Insys agrees to pay $4.45 million to resolve Illinois opioid lawsuit

BOSTON Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.

U.S. Aug 18 2017

Health Watch Graphics